Comparison Effectiveness Analysis Between ACL Reconstruction and Rehabilitation in Peripheral and Main Capital in Indonesia
Cetjap-Asin
1 other identifier
observational
100
1 country
1
Brief Summary
The study was a prospective observational analysis of cases with complete ACL tears. A study was conducted between February 2021 to December 2024. All the patients attending those hospitals' emergency or outpatient departments (OPD) with knee injuries were evaluated for an ACL tear. Patients who meet inclusion criteria and consent to participate in the study will be observed for two years. Patients in Arifin Achmad Hospital Pekanbaru will follow rehabilitation treatment and optional delayed reconstruction after 12 weeks if needed, while patients in some hospitals in Jakarta and Bandung (Cipto Mangunkusumo Hospital, Gatot Subroto Army Hospital, Hasan Sadikin Hospital) will perform early reconstruction treatment. After receiving informed consent, all subjects received a self-administered patient questionnaire containing the International Knee Documentation Committee (IKDC) score, EQ5D3L, and Tegner Activity Level (TAL) scores. These questionnaires will be measured at 0, 12, 24, 48, and 96 weeks. Clinical value of the Lachman test and pivot shift test will be performed. One independent orthopedic surgeon will keep all records and evaluate the results. All costs for the treatment will be accounted for.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2021
CompletedFirst Posted
Study publicly available on registry
February 10, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 28, 2024
May 1, 2024
3.3 years
January 26, 2021
May 23, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change of Questionnaire of International Knee Documentation Committee (IKDC Questionnaire)
IKDC is a subjective patient reported outcome measure for knee specific disease. Scoring in range 0-100, which 0 is lowest score, and 100 is a highest score
IKDC questionnaire was measured at pre operation (0 month), 3rd month, 6th month, 12th month, 24th month
Secondary Outcomes (4)
Change of Lachman Test
at pre operation (0 month), 12th month, 24th month
Change of Pivot shift test
at pre operation (0 month),12th month, 24th month
Change of Questionnaire of EQ5D
at pre operation (0 month),12th month, 24th month
Total cost of treatment
at 12th and 24 months
Study Arms (2)
ACL Reconstruction Group
This group received reconstruction treatment in Cipto Mangunkusumo Hospital, Gatot Subroto Hospital, Hasan Sadikin Hospital
Rehabilitation Group
This group received rehabilitation treatment with optional delayed reconstruction if needed in Arifin Achmad Hospital, Pekanbaru
Interventions
ACL Reconstruction surgery is a procedure to treat ACL injury by replacing the torn ligament with another. ACL Rehabilitation treatment is a procedure to treat ACL injury by muscle strengthening and exercise
Eligibility Criteria
Young active population
You may qualify if:
- Age between 18 to 40 years
- Either sex
- Isolated ACL tear not more than six weeks old to a previously uninjured knee or less than six months with showing acute symptoms (inflammation, swelling, knee effusion)
- Tegner Activitiy Level of 5-9.
You may not qualify if:
- Professional athletes or military
- Collateral ligament rupture
- Full-thickness cartilage lesion visualized
- TAL below 5
- Meniscal tear grade III on MRI.
- Pregnancy
- A history of deep vein thrombosis (DVT) or a disorder of the coagulative system
- Claustrophobia
- General systemic disease affecting physical function, any other condition or treatment interfering with the completion of the trial, including patients with metal devices or motion disorders
- Hyperlaxity with a Beighton score of more than 4
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitas Riaulead
Study Sites (1)
Arifin Achmad Hospital
Pekanbaru, Riau, 28133, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- dr
Study Record Dates
First Submitted
January 26, 2021
First Posted
February 10, 2021
Study Start
March 1, 2021
Primary Completion
June 30, 2024
Study Completion
December 31, 2024
Last Updated
May 28, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share